Showing results (1151-1160 of 2,691) with videos related to
Sort By:
Pageof 270
The Lancet. Infectious Diseases|November 7, 2016
New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspectiveBenedetta Allegranzi, Peter Bischoff, Stijn de Jonge, et al.The Lancet. Infectious Diseases|December 5, 2016
Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling studyKathy Leung, Marc Lipsitch, Kwok Yung Yuen, et al.The Lancet. Infectious Diseases|March 9, 2019
Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control studyMarcelo Low, Ami Neuberger, Thomas M Hooton, et al.The Lancet. Infectious Diseases|March 15, 2017
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapyWilliam D Rawlinson, Suresh B Boppana, Karen B Fowler, et al.The Lancet. Infectious Diseases|March 15, 2017
Effectiveness of interventions for diagnosis and treatment of tuberculosis in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic reviewCharlotte C Heuvelings, Sophia G de Vries, Patrick F Greve, et al.The Lancet. Infectious Diseases|August 17, 2019
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trialSonya Abraham, Helene B Juel, Peter Bang, et al.The Lancet. Infectious Diseases|November 14, 2018
Familiar barriers still unresolved-a perspective on the Zika virus outbreak research responseMarion Koopmans, Xavier de Lamballerie, Thomas Jaenisch, et al.The Lancet. Infectious Diseases|October 22, 2018
Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational studyNdivhuho A Makhado, Edith Matabane, Mauro Faccin, et al.The Lancet. Infectious Diseases|October 23, 2018
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countriesAngela Loyse, Jessica Burry, Jennifer Cohn, et al.The Lancet. Infectious Diseases|April 2, 2017
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised studyJames S McCarthy, Julie Lotharius, Thomas Rückle, et al.Pageof 270